Quantcast

Latest FDA Stories

2014-06-25 04:20:59

LEXINGTON, Massachusetts, June 25, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey granted Shire's summary judgment motion in a patent infringement lawsuit, holding that certain claims of the patents protecting Vyvanse(R) (lisdexamfetamine dimesylate) were both infringed and valid. The ruling prevents the five pharmaceutical manufacturers (the ANDA Defendants) who...

2014-06-24 23:14:41

There are several common mistakes in ANDA submissions that can be avoided to ensure speedy approval. Learn what those mistakes are and what to do about them on July 15 at the FDAnews webinar led by 30-year industry expert Dr. Andy Papas, Vice President of Regulatory Affairs at NSF Health Sciences Pharma Biotech. Falls Church, VA (PRWEB) June 24, 2014 Expedite Your FDA Generic Drug Approval: Deliver Flawless ANDAs the First Time **FDAnews Webinar** July 15, 2014 — 1:30 p.m. – 3:00...

2014-06-24 23:13:53

In response to a new FDA testosterone warning, The Onder Law Firm has updated its Testim Testosterone Lawsuit Center website, where the firm offers timely news updates and no-obligation Testim lawsuit case review with an attorney. St. Louis, MO (PRWEB) June 24, 2014 Attorneys representing national Testim lawsuits announce an expansion of their website, the Testim Testosterone Lawsuit Center, in response to a new FDA testosterone warning*. News broke late last week that the FDA will...

2014-06-24 23:13:50

On June 20, the FDA issued a warning that Docetaxel may cause intoxication. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 24, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Docetaxel. The FDA issued a safety communication on June 20, warning that Docetaxel may cause patients to experience...

2014-06-24 08:30:47

PORTLAND, Ore., June 24, 2014 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR; "Semler"), an emerging medical risk-assessment company whose mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services, today announced the appointment of global sales and marketing expert Scott Ashworth to the position of executive vice president of global...

2014-06-24 08:30:22

FDA now requires general product label warnings about increased risk ALTON, Ill., June 24, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) announced late last week there has been another risk linked to testosterone treatments. The FDA now requires manufacturers of testosterone or low-T products to add a general label warning about the increased risk for blood clots in veins to their prescription testosterone treatments. Blood clots in the veins, also known as venous...

2014-06-23 23:11:50

On June 20, the FDA announced that all lots of HydroFinity Hydrophilic Guidewires, by NDC/Covidien, are recalled due to outer jack damage. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 23, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Hydrophilic Guidewires. The FDA announced on June 20, that...

2014-06-23 23:11:48

Lawyers representing national Androgel lawsuits at The Onder Law Firm update FDA warning information on testosterone risks and offer free Androgel lawsuit case review for individuals seeking to file an Androgel testosterone lawsuit related to heart attack or stroke. St. Louis, MO (PRWEB) June 23, 2014 Attorneys handling Androgel lawsuits at The Onder Law Firm are providing up-to-date Androgel information at their website, the Androgel Testosterone Lawsuit Center, in light of a June 19,...

2014-06-23 23:02:26

The Firm is evaluating testosterone treatment lawsuits on behalf of men who may have suffered life-threatening cardiovascular injuries, including heart attacks, strokes and blood clots, due to low testosterone therapy. New York, NY (PRWEB) June 23, 2014 As testosterone lawsuit (http://www.testosteronelawsuitclaims.com/) filings continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the Food & Drug Administration (FDA) is warning of a potential risk for venous blood clots...

2014-06-23 16:25:10

IRVINE, Calif., June 23, 2014 /PRNewswire/ -- Central Admixture Pharmacy Services, Inc. (CAPS(®)) announced that its San Diego location has registered with the FDA as a 503B Outsourcing Facility. CAPS San Diego joins CAPS Lehigh Valley as the second CAPS facility registered under section 503B of the Drug Quality and Security Act (DQSA) as an Outsourcing Facility for anticipatory compounding. The law modified the Federal Food Drug and Cosmetic Act (FFDCA) by creating the new section...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.